Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis

References

• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• ZhangGWLinJHQianJPZhouJIdentification of risk and prognostic factors for patients with clonorchiasis-associated intrahepatic cholangiocarcinomaAnn Surg Oncol201421113628363724781504
   PubMed Web of Science ®Google Scholar
• SriampornSPisaniPPipitgoolVSuwanrungruangKKamsa-ardSParkinDMPrevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast ThailandTrop Med Int Health20049558859415117303
   PubMed Web of Science ®Google Scholar
• ChamadolNPairojkulCKhuntikeoNHistological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patientsJ Hepatobiliary Pancreat Sci201421531632224420706
   PubMed Web of Science ®Google Scholar
• MaithelSKGamblinTCKamelICorona-VillalobosCPThomasMPawlikTMMultidisciplinary approaches to intrahepatic cholangiocarcinomaCancer2013119223929394223963845
   PubMed Web of Science ®Google Scholar
• AndersenJBThorgeirssonSSGenetic profiling of intrahepatic cholangiocarcinomaCurr Opin Gastroenterol201228326627222395571
   PubMed Web of Science ®Google Scholar
• BlechaczBGoresGJCholangiocarcinoma: advances in pathogenesis, diagnosis, and treatmentHepatology200848130832118536057
   PubMed Web of Science ®Google Scholar
• BrandiGVenturiMPantaleoMAErcolani G;GICOCholangiocarcinoma: current opinion on clinical practice diagnostic and therapeutic algorithms: a review of the literature and a long-standing experience of a referral centerDig Liver Dis201648323124126769568
   PubMedGoogle Scholar
• LeeYSDuttaAMicroRNAs in cancerAnnu Rev Pathol2009419922718817506
   PubMed Web of Science ®Google Scholar
• CroceCMCalinGAmiRNAs, cancer, and stem cell divisionCell200512216716009126
   PubMed Web of Science ®Google Scholar
• BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
   PubMed Web of Science ®Google Scholar
• MitchellPSParkinRKKrohEMCirculating microRNAs as stable blood-based markers for cancer detectionProc Natl Acad Sci U S A200810530105131051818663219
   PubMed Web of Science ®Google Scholar
• WangLGGuJSerum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasisCancer Epidemiol2012361e61e6722018950
   PubMed Web of Science ®Google Scholar
• KishimotoTEguchiHNaganoHPlasma miR-21 is a novel diagnostic biomarker for biliary tract cancerCancer Sci2013104121626163124118467
   PubMed Web of Science ®Google Scholar
• SilakitRLoilomeWYongvanitPCirculating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicatorJ Hepatobiliary Pancreat Sci2014211286487225131257
   PubMed Web of Science ®Google Scholar
• LevyCLympJAnguloPGoresGJLarussoNLindorKDThe value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitisDig Dis Sci20055091734174016133981
   PubMed Web of Science ®Google Scholar
• ChengQFengFZhuLCirculating miR-106a is a novel prognostic and lymph node metastasis indicator for cholangiocarcinomaSci Rep201551610326534789
   PubMed Web of Science ®Google Scholar
• WhitingPRutjesAWReitsmaJBBossuytPMKleijnenJThe development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviewsBMC Med Res Methodol200332514606960
   PubMedGoogle Scholar
• StroupDFBerlinJAMortonSCMeta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) groupJAMA2000283152008201210789670
   PubMed Web of Science ®Google Scholar
• ParmarMKTorriVStewartLExtracting summary statistics to perform meta-analyses of the published literature for survival endpointsStat Med19981724281528349921604
   PubMed Web of Science ®Google Scholar
• ReitsmaJBGlasASRutjesAWScholtenRJBossuytPMZwindermanAHBivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviewsJ Clin Epidemiol2005581098299016168343
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• WuYFuXZhuXPrognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysisJ Cancer Res Clin Oncol2011137588789620878529
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• SiricaAECholangiocarcinoma: molecular targeting strategies for chemoprevention and therapyHepatology200541151515690474
   PubMed Web of Science ®Google Scholar
• ChuXZhaoPLvYLiuLDecreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinomaInt J Clin Exp Pathol20158132833625755719
   PubMed Web of Science ®Google Scholar
• WuTCyclooxygenase-2 and prostaglandin signaling in cholangiocarcinomaBiochim Biophys Acta20051755213515015921858
   PubMed Web of Science ®Google Scholar
• NittaTSatoYRenXSAutophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinomaInt J Clin Exp Pathol2014784913492125197362
   PubMed Web of Science ®Google Scholar
• PatelTCholangiocarcinoma--controversies and challengesNat Rev Gastroenterol Hepatol20118418920021460876
   PubMed Web of Science ®Google Scholar
• InceATYıldızKBaysalBRoles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructionsTurk J Gastroenterol2014252162169
   PubMed Web of Science ®Google Scholar
• HuangLChenWLiangPSerum CYFRA 21-1 in biliary tract cancers: a reliable biomarker for gallbladder carcinoma and intrahepatic cholangiocarcinomaDig Dis Sci20156051273128325487191
   PubMed Web of Science ®Google Scholar
• IorioMVFerracinMLiuCGMicroRNA gene expression deregulation in human breast cancerCancer Res200565167065707016103053
   PubMed Web of Science ®Google Scholar
• GramantieriLFerracinMFornariFCyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinomaCancer Res200767136092609917616664
   PubMed Web of Science ®Google Scholar
• YanaiharaNCaplenNBowmanEUnique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell20069318919816530703
   PubMed Web of Science ®Google Scholar
• BernuzziFMarabitaFLleoASerum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinomaClin Exp Immunol20161851617126864161
   PubMed Web of Science ®Google Scholar
• SelaruFMOlaruAVKanTMicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3Hepatology20094951595160119296468
   PubMed Web of Science ®Google Scholar
• SilakitRLoilomeWYongvanitPUrinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk groupParasitol Int201766447948526456596
   PubMed Web of Science ®Google Scholar
• WangLJHeCCSuiXMiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTENOncotarget2015685932594625803229
   PubMed Web of Science ®Google Scholar
• HuangQLiuLLiuCHMicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosisAsian Pac J Cancer Prev201314282983423621247
   PubMedGoogle Scholar
• AliHEAAbdel HameedREffatHCirculating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinomaClin Res Hepatol Gastroenterol2017414e51e6228750770
   PubMed Web of Science ®Google Scholar
• AlexanderLFHarriPLittleBMorenoCCMittalPKMagnetic resonance imaging of primary hepatic malignancies in patients with and without chronic liver disease: a pictorial reviewCureus201798e153928989828
   PubMedGoogle Scholar
• Peraldo NeiaCCavalloniGChiorinoGOstanoPAgliettaMLeoneFGene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell lineOncotarget2016752867668678027902465
   PubMedGoogle Scholar
• LoosenSHSchuellerFTrautweinCRoySRoderburgCRole of circulating microRNAs in liver diseasesWorld J Hepatol201791258659428515844
   PubMed Web of Science ®Google Scholar
• OlaizolaPLee-LawPYArbelaizAMicroRNAs and extracellular vesicles in cholangiopathiesBiochim Biophys Acta201818644 Pt B1293130728711597
   PubMed Web of Science ®Google Scholar
• LiZShenJChanMTVWuWKKThe role of microRNAs in intrahepatic cholangiocarcinomaJ Cell Mol Med201721117718427619971
   PubMed Web of Science ®Google Scholar
• ChenYLiuDLiuPChenYYuHZhangQIdentification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray dataMol Med Rep20171531051105628098904
   PubMed Web of Science ®Google Scholar
• LiJYaoLLiGmiR-221 promotes epithelial-mesenchymal transition through targeting PTEN and forms a positive feedback loop with β-catenin/c-Jun signaling pathway in extra-hepatic cholangiocarcinomaPLoS One20151010e014116826501139
   PubMed Web of Science ®Google Scholar
• QiaoPLiGBiWYangLYaoLWuDmicroRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathwayBMC Cancer20151546926077733
   PubMed Web of Science ®Google Scholar
• WangLJZhangKLZhangNSerum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinomaOncotarget2015621186311864026087181
   PubMedGoogle Scholar
• WangSYinJLiTUpregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinomaOncol Rep201533281982525482320
   PubMed Web of Science ®Google Scholar
• Correa-GallegoCMaddaloDDoussotACirculating plasma levels of microRNA-21 and microRNA-221 are potential diagnostic markers for primary intrahepatic cholangiocarcinomaPLoS One2016119e016369927685844
   PubMed Web of Science ®Google Scholar
• ChuCHChouWWangFYehCNChenTCYehTSExpression profile of microRNA-200 family in cholangiocarcinoma arising from choledochal cystJ Gastroenterol Hepatol20163151052105926479153
   PubMed Web of Science ®Google Scholar
• ChenYLuoJTianRSunHZouSmiR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in hilar cholangiocarcinomaDig Dis Sci20115661693170121086164
   PubMed Web of Science ®Google Scholar
• LiJGaoBHuangZPrognostic significance of microRNA-203 in cholangiocarcinomaInt J Clin Exp Pathol2015889512951626464713
   PubMed Web of Science ®Google Scholar
• ChusornPNamwatNLoilomeWOverexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasisTumour Biol20133431579158823417858
   PubMedGoogle Scholar
• DengYChenYIncreased expression of miR-29a and its prognostic significance in patients with cholangiocarcinomaOncol Res Treat201740312813228118648
   PubMed Web of Science ®Google Scholar
• LiHZhouZQYangZRMicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinomaHepatology201766113615128194813
   PubMed Web of Science ®Google Scholar
• WangJXieCPanSN-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathwayHepatology20166451606162227533020
   PubMed Web of Science ®Google Scholar
• GarajovaIBrandiGBiascoGMiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapyEur J Cancer201551S33S33
   Web of Science ®Google Scholar